0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query mrrpb5 global her 2 targeted drugs breast cancer market size status forecast 2019 2025.Your search for "" gave back 1533058 results.
HER2, also known as human epidermal growth factor receptor 2, is an important prognostic factor for breast cancer.HER2 is also expressed on the...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
HER2, also known as human epidermal growth factor receptor 2, is an important prognostic factor for breast cancer.HER2 is also expressed on the...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Drugs In Development, 2021 Summary According to the recently published report 'Histone...
Catalog:
Global Markets Direct
August 2021
Price: USD 3,500.00
The global HER2 Tumor Marker Testing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a...
Catalog:
GIR
November 2023
Price: USD 3,480.00
Women’s Health - Assessing the Need for a Targeted and Specialized Approach Summary Many of the diseases and conditions that affect mainly women are...
Catalog:
CBR Pharma Insights
January 2015
Price: USD 2,995.00
Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) - Pipeline Review, H1 2018 Summary According to the...
Catalog:
Global Markets Direct
May 2018
Price: USD 3,500.00
HER2 is the target of the monoclonal antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Histone Deacetylase 3 (SMAP45 or RPD3 2 or HDAC3 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule...
Catalog:
Global Markets Direct
August 2022
Price: USD 3,500.00
Medicines include tamoxifen (Nolvadex) for women before and after menopause and aromatase inhibitors including anastrozole (Arimidex), exemestane (...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Chemotherapy is systemic drug treatment intended to stop cancer cells from dividing and growing. Many different types of chemotherapy drugs are used...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
Nuclear Factor Erythroid 2 Related Factor 2 (HEBP1 or Nuclear Factor Erythroid Derived 2 Like 2 or NFE2L2) Drugs in Development by Therapy Areas and...
Catalog:
Global Markets Direct
April 2022
Price: USD 3,500.00
Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players,...
Catalog:
Global Markets Direct
August 2022
Price: USD 3,500.00
HER2, also known as human epidermal growth factor receptor 2, is an important prognostic factor for breast cancer.HER2 is also expressed on the...
Catalog:
LPI
February 2023
Price: USD 3,660.00
RAF Proto Oncogene Serine, Threonine Protein Kinase (Proto Oncogene c RAF or RAF1 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA,...
Catalog:
Global Markets Direct
November 2022
Price: USD 3,500.00
Lapatinib (INN), used in the form of lapatinib ditosylate, (USAN) (Tykerb/Tyverb, GSK) is an orally active drug for breast cancer and other solid...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
